HCV-GLUE is based on the GLUE software framework, both are developed by the
MRC-University of Glasgow Centre for Virus Research.
The drug resistance features are developed in concert with the Public Health England Virus Reference Department and the PHE HCV Resistance Group.
Contact Josh Singer with questions or feedback.
Please note this is beta software, still undergoing development and testing before its official release.